MarketCap
Facebook
X
Telegram
Baudax Bio Kurzfristige Verbindlichkeiten | BXRX
Kurzfristige Verbindlichkeiten Jährlich Baudax Bio
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.5 M | 15.6 M | 18.1 M | 7.71 M | 22.8 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22.8 M | 7.71 M | 17.1 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Happiness Biotech Group Limited
HAPP
|
6.4 M | - | 1.35 % | $ 17.8 M |  China |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B |  USA |
 |
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | USA |
 |
I-Mab
IMAB
|
412 M | - | - | $ 866 M | China |
 |
Corner Growth Acquisition Corp.
COOL
|
30.2 K | - | -0.89 % | $ 114 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
100 M | - | - | $ 2.18 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Alpine Immune Sciences
ALPN
|
42 M | - | - | $ 2.17 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
47.5 M | - | - | $ 269 M | USA |
 |
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | USA |
 |
Geron Corporation
GERN
|
112 M | $ 1.42 | -2.07 % | $ 947 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M | - | - | $ 231 M | USA |
 |
Inhibikase Therapeutics
IKT
|
8.3 M | $ 2.33 | - | $ 229 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M | - | -1.58 % | $ 28.1 M | China |
 |
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M |  Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
31 M | - | - | $ 384 M |  Britain |
 |
Gracell Biotechnologies
GRCL
|
221 M | - | - | $ 3.37 B | China |
 |
Jaguar Health
JAGX
|
40.7 M | $ 0.96 | -6.48 % | $ 2.24 M | USA |
 |
Johnson & Johnson
JNJ
|
54.1 B | $ 263.4 | 1.58 % | $ 634 B | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Alkermes plc
ALKS
|
543 M | $ 52.89 | -0.15 % | $ 8.71 B |  Irlanda |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
Achieve Life Sciences
ACHV
|
9.08 M | $ 6.1 | -1.13 % | $ 266 M | USA |
 |
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
9.71 M | - | 4.14 % | $ 49.1 M | USA |